FBSRX
Price
$39.47
Change
-$0.09 (-0.23%)
Updated
Nov 7 closing price
VMVIX
Price
$67.28
Change
-$0.14 (-0.21%)
Updated
Nov 7 closing price
Ad is loading...

FBSRX vs VMVIX

Header iconFBSRX vs VMVIX Comparison
Open Charts FBSRX vs VMVIXBanner chart's image
Franklin Mutual U.S. Mid Cap Value R
Price$39.47
Change-$0.09 (-0.23%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Investor
Price$67.28
Change-$0.14 (-0.21%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
FBSRX vs VMVIX Comparison Chart
Loading...
VS
FBSRX vs. VMVIX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBSRX is a StrongBuy and VMVIX is a Buy.

FUNDAMENTALS
Fundamentals
VMVIX pays higher dividends than FBSRX: VMVIX (2.03) vs FBSRX (0.89). FBSRX was incepted earlier than VMVIX: FBSRX (23 years) vs VMVIX (18 years). FBSRX is a more actively managed with annual turnover of: 64.21 vs. VMVIX (22.00). FBSRX has a lower initial minimum investment than VMVIX: FBSRX (1000) vs VMVIX (3000). VMVIX annual gain was more profitable for investors over the last year : 31.58 vs. FBSRX (28.88). VMVIX return over 5 years is better than : 48.97 vs. FBSRX (13.18).
FBSRXVMVIXFBSRX / VMVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years18 years-
Gain YTD15.57118.35185%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A30.9B-
Annual Yield % from dividends0.892.0344%
Returns for 1 year28.8831.5891%
Returns for 3 years-2.1615.55-14%
Returns for 5 years13.1848.9727%
Returns for 10 years-21.16100.01-21%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
QUIK8.170.53
+6.94%
QuickLogic Corp
DDD3.570.14
+4.08%
3D Systems Corp
LFST7.140.28
+4.08%
LifeStance Health Group
WWD172.525.95
+3.57%
Woodward
ARTL1.22-0.03
-2.40%
Artelo Biosciences